igf-1 semaglutide Differential Role of Insulin/IGF-1 Receptor Signaling in Muscle Growth and Glucose Homeostasis Insulin-like growth factor-1 deficiency and

Importantly, when patients stop semaglutide, the weight they regain tends to be mostly fat mass not lean mass, leaving them potentially worse off in terms of joint support and musculoskeletal health

At Generations Family Practice, this treatment may be considered for patients with obesity, excess weight, or type 2 diabetes who need medical support alongside healthy lifestyle changes

When fibre is fermented by the trillions of bacteria that live in our intestines, the resultant byproduct, called short chain fatty acids, stimulates the production of GLP-1

For obesity management, glucagon-like peptide 1 (GLP1) agonists like Zepbound (tirzepatide) and Wegovy (semaglutide) may be safer and more effective, especially when combined with lifestyle changes such as increased physical activity

68.Hansen H.H., Pors S., Andersen M.W., Vyberg M., Nhr-Meldgaard J., Nielsen M.H., et al

Different plans have different preferred medications